Cargando…
A Case of Lymphocyte-Rich Hepatocellular Carcinoma in a Patient Who Was Treated for Colon Cancer
Hepatocellular carcinoma (HCC) primarily originates in the liver with hepatic differentiation. However, HCCs are not homogenous, and approximately 35% of HCC cases are classified as histopathological variants that present distinct pathologic characteristics. In particular, the lymphocyte-rich varian...
Autores principales: | Song, Jae Won, Chun, Ho Soo, Lee, Jae Seung, Lee, Hye Won, Kim, Beom Kyung, Kim, Seung Up, Park, Jun Yong, Ahn, Sang Hoon, Park, Young Nyun, Han, Dai Hoon, Kim, Do Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Liver Cancer Association
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035728/ https://www.ncbi.nlm.nih.gov/pubmed/37384276 http://dx.doi.org/10.17998/jlc.21.1.69 |
Ejemplares similares
-
Predictors of Complete Response in Patients with Hepatocellular Carcinoma Treated with Trans-Arterial Radioembolization
por: Kim, Yuna, et al.
Publicado: (2021) -
Clinical characteristics and prognosis of Korean patients with hepatocellular carcinoma with respect to etiology
por: Jang, Wonjoon, et al.
Publicado: (2022) -
Validation of Pre-/Post-TACE-Predict Models among Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization
por: Kim, David Sooik, et al.
Publicado: (2021) -
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals
por: Lee, Hye Won, et al.
Publicado: (2020) -
Negligible risks of hepatocellular carcinoma during biomarker-defined immune-tolerant phase for patients with chronic hepatitis B
por: Jeon, Mi Young, et al.
Publicado: (2021)